XML 92 R75.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefit Plans, Share Based Compensation, Equity Instruments Other Than Options (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Vested and Expected-to-Vest Options, Weighted Average Remaining Contractual Term at Period End 1 year    
Fair value of RSUs, RSAs and PSAs $ 187.3 $ 185.7 $ 202.7
Restricted Stock Units (RSU) and Restricted Stock | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Restricted Stock Units (RSU) and Restricted Stock | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Restricted Stock Units (RSUs)      
Restricted Stock Units And Performance Share Awards Activities      
Awards Granted, Number of Shares 7.9    
Awards Assumed, Number of Shares 0.1    
Awards Vested, Number of Shares (6.7)    
Awards Canceled, Number of Shares (2.1)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Awards Granted, Weighted Average Grant-Date Fair Value (in USD per share) $ 27.54    
Awards Assumed, Weighted Average Grant-Date Fair Value (in USD per share) 26.91    
Awards Vested, Weighted Average Grant-Date Fair Value (in USD per share) 23.99    
Awards Canceled, Weighted Average Grant-Date Fair Value (in USD per share) 24.97    
Ending Balance, Weighted Average Grant-Date Fair Value (in USD per share) $ 27.53    
Performance Shares (PSAs)      
Restricted Stock Units And Performance Share Awards Activities      
Awards Granted, Number of Shares 0.9    
Awards Vested, Number of Shares (0.5)    
Awards Canceled, Number of Shares (0.5)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Awards Granted, Weighted Average Grant-Date Fair Value (in USD per share) $ 27.52    
Awards Vested, Weighted Average Grant-Date Fair Value (in USD per share) 24.29    
Awards Canceled, Weighted Average Grant-Date Fair Value (in USD per share) 25.25    
Ending Balance, Weighted Average Grant-Date Fair Value (in USD per share) $ 23.45    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options,Performance Goal, Number of Shares 0.7    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Number of Shares Modified 1.4    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost $ 6.7    
Performance Shares (PSAs) | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 2 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options,Performance Goal, Number of Shares 0.0    
Performance Shares (PSAs) | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options,Performance Goal, Number of Shares 0.9    
RSA      
Restricted Stock Units And Performance Share Awards Activities      
Awards Vested, Number of Shares (0.5)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Awards Vested, Weighted Average Grant-Date Fair Value (in USD per share) $ 23.72    
Ending Balance, Weighted Average Grant-Date Fair Value (in USD per share) $ 24.66    
RSUs, RSAs, and PSAs      
Restricted Stock Units And Performance Share Awards Activities      
Beginning Balance, Number of Shares 20.9    
Ending Balance, Number of Shares 19.5 20.9  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Beginning Balance, Weighted Average Grant-Date Fair Value (in USD per share) $ 24.05    
Ending Balance, Weighted Average Grant-Date Fair Value (in USD per share) $ 25.39 $ 24.05  
Weighted Average Remaining Contractual Term (In Years) 11 months 26 days  
RSUs and PSAs, Aggregate Intrinsic Value at Period End $ 555.3  
Vested and Expected-to-Vest RSUs and PSAs, Number of Shares at Period End 15.9    
Vested and Expected-to-Vest RSUs and PSAs, Grant Date Fair Value (in USD per share) $ 25.76    
Vested and Expected-to-Vest Options, Weighted Average Remaining Contractual Term at Period End 1 year 1 month 6 days    
Vested and Expected-to-Vest RSUs and PSAs, Aggregate Intrinsic Value $ 452.3